PAPACCIO, Federica
 Distribuzione geografica
Continente #
NA - Nord America 578
EU - Europa 324
AS - Asia 289
SA - Sud America 83
OC - Oceania 4
AF - Africa 3
Totale 1.281
Nazione #
US - Stati Uniti d'America 571
SG - Singapore 165
RU - Federazione Russa 127
IT - Italia 81
BR - Brasile 77
CN - Cina 37
HK - Hong Kong 31
IE - Irlanda 27
DE - Germania 26
KR - Corea 25
NL - Olanda 19
IN - India 10
GB - Regno Unito 8
UA - Ucraina 8
AT - Austria 6
ES - Italia 5
BD - Bangladesh 4
BE - Belgio 4
CA - Canada 4
FI - Finlandia 4
TR - Turchia 4
AU - Australia 3
FR - Francia 3
JP - Giappone 3
UZ - Uzbekistan 3
AR - Argentina 2
EC - Ecuador 2
HU - Ungheria 2
LK - Sri Lanka 2
MX - Messico 2
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
JO - Giordania 1
KE - Kenya 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 1.281
Città #
Chandler 128
Princeton 95
Singapore 72
Moscow 53
Ashburn 41
Hong Kong 31
Dublin 27
Andover 24
Redwood City 23
Dallas 20
Wilmington 18
Ann Arbor 15
Naples 13
Amsterdam 12
Nuremberg 10
Beijing 8
Seattle 8
The Dalles 8
San Francisco 7
New York 6
Sarno 6
Los Angeles 5
Munich 5
Washington 5
Milan 4
Springfield 4
Vienna 4
Aprilia 3
Columbus 3
Duncan 3
Edinburgh 3
Hangzhou 3
Houston 3
New Delhi 3
Norwalk 3
Paris 3
Rome 3
Tashkent 3
Tokyo 3
Assago 2
Atlanta 2
Barbacena 2
Bourne End 2
Brooklyn 2
Budapest 2
Campinas 2
Campo Grande 2
Castellammare di Stabia 2
Chennai 2
Chicago 2
Cuiabá 2
Curitiba 2
Dhaka 2
Ferrara 2
Guarulhos 2
Islington 2
Istanbul 2
Jacksonville 2
Lappeenranta 2
Madrid 2
Montreal 2
Poggiomarino 2
Pune 2
São Paulo 2
Weifang 2
Yubileyny 2
Alto Jequitibá 1
Amman 1
Amparo do Serra 1
América 1
Anápolis 1
Apizaco 1
Aracaju 1
Areia Branca 1
Artur Nogueira 1
Atibaia 1
Aydin 1
Bacabal 1
Bady Bassitt 1
Balıkesir 1
Baoding 1
Barishal 1
Belo Horizonte 1
Belvedere Spinello 1
Boardman 1
Bogotá 1
Boston 1
Brejões 1
Brighton 1
Bristol 1
Brussels 1
Buffalo 1
Böblingen 1
Calgary 1
Camaçari 1
Cambé 1
Candeias 1
Caruaru 1
Caserta 1
Catende 1
Totale 776
Nome #
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer 57
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress 53
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 47
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy 44
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction" 43
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development 42
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo 41
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation 41
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo 39
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study 38
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy 36
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer 36
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: Case report and translational study 35
Implication of the Hedgehog pathway in hepatocellular carcinoma 35
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy 35
Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells 35
Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance 34
In the literature: August 2018 34
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization 33
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial 32
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells 30
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 30
Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer 29
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 27
How organoids can improve personalized treatment in patients with gastro-esophageal tumors 25
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 24
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer 23
Adipose Stem Cells and Their Interplay with Cancer Cells and Mitochondrial Reservoir: A New Promising Target 22
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision 22
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence 21
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 20
Circulating cancer stem cells: an interesting niche to explore 18
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy 17
Insulitis in Human Type 1 Diabetic Pancreas: From Stem Cell Grafting to Islet Organoids for a Successful Cell-Based Therapy 17
Stemness markers of osteosarcoma 17
Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis 17
ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition 16
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance 15
Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. 15
Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC) 14
Will Organoids Fill the Gap towards Functional Precision Medicine? 14
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 14
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 12
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites 12
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor 12
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients 12
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 11
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids 11
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC 11
Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine 11
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites 10
Efficacy of sequential treatment with first, second and third generation EGFR inhibitors and role of Hedgehog pathway in the acquisition of resistance in in vivo NSCLC models 9
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models 9
CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations 9
Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models 9
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors 8
Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype 7
Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial 7
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy 7
Met/Axl system as a dual target in the mesothelioma pathway and invasiveness 7
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer 6
Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations 6
New insights from KISS activity: a prognostic biomarker in malignant pleural mesothelioma 6
Synergistic effect of vismodegib and cisplatin in NSCLC models via autophagy 5
Patient-derived organoids as a tool for modelling localized colorectal cancer 4
Totale 1.438
Categoria #
all - tutte 9.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 25 30 13 4 1 5 3 9 3
2021/2022127 3 0 2 0 1 0 0 10 26 0 16 69
2022/2023370 26 0 6 42 46 72 6 52 83 2 30 5
2023/2024202 7 14 10 4 10 34 4 8 28 2 9 72
2024/2025630 8 24 37 17 27 76 107 34 95 40 72 93
2025/202616 16 0 0 0 0 0 0 0 0 0 0 0
Totale 1.438